Nonalcoholic
Steatohepatitis (NASH)
Explore facts and recommendations for pharmacological treatments for Nonalcoholic Steatohepatitis (NASH).
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
Investigational Development of Semaglutide for NASH
Brief overview of the Novo Nordisk clinical development program investigating the effect of semaglutide in NASH.
NASH Core Curriculum: Current Management (IME content)
Analysis of the effects of diet, exercise, and various pharmacotherapies on NASH and weight loss.
NASH Core Curriculum: Emerging Management (IME content)
Exploration of potential NASH treatments in development, including data on hepatic and extrahepatic outcomes.
Continuing Education
Find accredited opportunities in nonalcoholic steatohepatitis (NASH) education.
NASH
NASH
Looking for additional resources?
Explore other libraries or search the Exchange.
Additional Information
Speak to a live medical representative.
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.
